RLT-Connect

RLT-Connect is an online platform designed to facilitate collaboration between healthcare professionals seeking radioligand therapy for their patients who cannot afford it, and Radioisotope suppliers willing to donate doses to make this life-changing treatment accessible to those in need.

Changing lives, one patient at a time

Access to radioligand therapies is deeply unequal around the world:

Technology is only available to a small number of cancer patients
Access is dependent on where the patient lives
In most low- and middle-income new radiopharmaceuticals are paid out of pocket

It’s all about connections.

Unfortunately, connections are low and sometimes non-existent. That’s why we, at the Oncidium foundation, developed it.

Acces the platform

RLT-Connect is a platform that connects healthcare practitioners and radioisotope companies that donate radiopharmaceutical doses, enabling treatment doe patients in financial need.

How can I take part in this initiative?

Donate radioisotopes

Are you a radioisotope manufacturer willing to donate?

Enroll your hospital

Are you a physician working with radioligand therapy in cancer care?

Support the cause

Everyone can support the cause through donations.

Learn more

In establishing "RLT-Connect", the Oncidium foundation has forged a comprehensive ecosystem: a true chain of solidarity extending from therapy centers to radiopharmacies and radioisotope suppliers, all united in pursuit of a common mission to ensure that every cancer patient has an equal opportunity to access a potentially life-changing technology, wherever and whoever they are.
Rebecca Lo BueCEO of the Oncidium foundation

Access to radiotheranostics is often constrained due to limited resources and logistical challenges. This platform will simplify the process, ensuring that we can provide the best care possible; thus, enabling the best of all worlds for everyone involved, and primarily for patients.
Dr. Cecilia CarrerasHead of Nuclear Medicine & PET/CT Ángeles Lomas Hospital, Mexico

We are happy to support the Oncidium foundation with a donation of our high-quality medical radioisotopes. ITM stands behind the foundation's mission to serve patients in need and to accelerate global access to radiotheranostics.
Dr. Steffen SchusterCEO of ITM

Our recent donation of radioisotopes through the RLT-Connect platform is a testament to our commitment to fostering social responsibility. We firmly believe that by working together, we can make a meaningful difference in the lives of cancer patients, ensuring they receive the timely care and support they deserve. The Oncidium foundation's dedication to this cause is truly inspiring, and we look forward to continuing this meaningful collboration.
Çağla MirasyedioğluSr. Global Product Manager, Monrol Nuclear Products Co.

At PanTera, we believe the benefits which radiopharmaceuticals create for cancer patients should be sustainably made available throught the entire world. The Oncidium foundation's coordiation efforts will strengthen the bond between the suppliers an the medical community, fostering collaboration and ccreating more resilient supply ecosystems. PanTera is proud and exited to contribute to that effort!
Sven Van den BergheCEO of PanTera

This life-saving project aligns perfectly with our commitment to advance the field of nuclear medicine. We are proud to partner with the Oncidium foundation in its endeavors to make radiotheranostics available for as many people as possible. We are delighted for the opportunity to contribute to making a difference in the lives of individuals who lack access to vital medical resources.
Keren Eyal-KotlizkyVP Business Dev. at Isotopia Molecular Imaging

Our generous supporters

Become a partner of RLT-Connect

FAQ

Have questions?

We’ve gathered the most frequently asked questions to help you better understand radioligand therapy, our mission, and how you can get involved. Whether you're a patient, healthcare professional, or supporter, this section offers clear and concise answers to guide you.